Concepedia

Maura N. Dickler

MN

Statistics

Publications

111

Citations

16.5K

H-Index

54

Active since

1988

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Dana-Farber Cancer Institute

Eli Lilly (United States)

University of California, San Francisco

Maura N. Dickler is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

1988–2021

111

Publications

111

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Kathy D. Miller, Linnea Chap, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2005 · 1.3K citations · Full text

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Pedram Razavi, Matthew T. Chang, Guotai Xu et al. · Cancer Cell · 2018 · 956 citations · Full text

, , +3

MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Maura N. Dickler, Sara M. Tolaney, Hope S. Rugo et al. · Clinical Cancer Research · 2017 · 669 citations · Full text

Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

Hope S. Rugo, R. Bryan Rumble, Erin Macrae et al. · Journal of Clinical Oncology · 2016 · 623 citations

1–5 of 111